Nine newer antipsychotics, called atypical antipsychotics, are used as "augmentation therapy," or add-ons to treat depression that hasn't responded to antidepressants or other treatments.

Schizophrenia drug Cobenfy, a key component in Bristol Myers Squibb’s plan to navigate a transition period of major loss of ...

The use of antipsychotic drugs to treat conditions ... disorder (PTSD), and some types of depression. (See Table 1 for list of drugs and their approved uses.) This is known as "off-label ...

All the newer atypical antipsychotics tested cause weight gain, some more than others. Patients with major depressive disorder also frequently require long-term drug treatment, especially those ...

The antipsychotic was begun at a dose of 7.5 mg daily to control atypical thinking and behavior. Acute mania developed within 2-3 weeks and gradually resolved with discontinuation of olanzapine.

Management of adverse events is a major concern of clinicians who use antipsychotic drugs. The incidence of motor side effects is dose dependent. Atypical antipsychotic drugs are less likely to ...

Antipsychotic drugs introduced over the past 15 years, often termed second-generation or atypical agents, were selected on the basis of a structural or pharmacological similarity to clozapine ...